Early Cancer Diagnosis in Primary Care - Lung Cancer & Prostate Cancer
Early Cancer Diagnosis in Primary Care - Lung Cancer & Prostate Cancer
批准号:
10045762
负责人:
金额:
$6.37万
依托单位:
依托单位国家:
英国
项目类别:
Grant for R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --
中文摘要
我们将使用一个数字健康平台来帮助早期识别肺癌和前列腺癌患者。这款数字健康产品将审查医疗记录,以识别患这类癌症风险增加的患者,包括年龄、生活方式选择、家族史和症状。*在早期诊断时,近九成(88%)肺癌患者将存活一年或更长时间,而在晚期诊断时,这一比例约为五分之一(19%)。*在早期诊断时,几乎每10名肺癌患者中就有6名(57%)能够存活5年或更长时间,而在晚期诊断时,这一数字几乎为每100名患者中有5名(3%)。*在早期诊断时,所有(100%)前列腺癌患者都能存活一年或更长时间,而在晚期诊断时,这一比例接近90%(88%)。*在早期诊断时,所有(100%)前列腺癌患者都能存活5年或更长时间,而在晚期诊断时,这一比例约为1 / 2(49%)。然后将这些数据提交给临床医生,以便他们决定是否需要进一步调查。我们的目标是在早期阶段增加对这些癌症的检测,从而改善患者的预后和预期寿命。如果这个项目成功了,我们可以用同样的原理在早期发现其他癌症。
英文摘要
We will be using a digital health platform to help early identification of patients with lung and prostate cancer. The digital health product will be reviewing medical notes to identify patients who have an increased risk of these types of cancers, including age, lifestyle choices, family history and symptoms.* When diagnosed at its earliest stage, almost 9 in 10 (88%) people with lung cancer will survive their disease for one year or more, compared with around 1 in 5 (19%) people when the disease is diagnosed at the latest stage.* When diagnosed at its earliest stage, almost 6 in 10 (57%) people with lung cancer will survive their disease for five years or more, compared with almost 5 in 100 (3%) people when the disease is diagnosed at the latest stage.* When diagnosed at its earliest stage, all (100%) people with prostate cancer will survive their disease for one year or more, compared with almost 9 in 10 (88%) people when the disease is diagnosed at the latest stage.* When diagnosed at its earliest stage, all (100%) people with prostate cancer will survive their disease for five years or more, compared with around 1 in 2 (49%) people when the disease is diagnosed at the latest stage.This data will then be presented to a clinician for them to make a decision on whether further investigations are required.We aim to increase the detection of these cancers at an early stage, thereby improving the outcome and life expectancy for patients.If this project is successful, we can use the same principle in detecting other cancers at an early stage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
-
批准号:81673007
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2016
-
负责人:金时
-
依托单位: